TVTX - Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California.

52W High

$25.29

52W Low

$11.50

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.79

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

17.67

EV/EBITDA (<8 favorable)

-5.67

EV/Revenue (<3 favorable)

6.02

P/S (TTM) (<3 favorable)

5.78

P/B (<3 favorable)

58.91

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.75%

Institutions (25–75% balanced)

117.25%

Shares Outstanding

89,139,000

Float

79,286,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

333,865,000

Gross Profit (TTM)

113,488,000

EPS (TTM)

-2.02

Profit Margin (>10% good)

-0.51%

Operating Margin (TTM) (higher better)

-0.11%

ROE (TTM) (>15% strong)

-7.06%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.12

Momentum

Bearish momentum

Value

1.1409

0.8797

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025